Rezolute, Inc. (NV) Share Price
NASDAQ: RZLT | Small CapRezolute, Inc. (NV) Stock Performance
Rezolute, Inc. (NV) Share Price Today
As of 30 October 2026, Rezolute, Inc. (NV)'s share price is $4.13. The stock opened at $4.31, compared to its previous close of $4.22. During today's trading session, Rezolute, Inc. (NV)'s share price traded between $4.08 and $4.31, with an average price of $4.19. Over the past 52 weeks, the stock has recorded a high of $11.43 and a low of $1.07. In terms of performance, Rezolute, Inc. (NV)'s share price has risen by 29.06% over the last six months and is down 55.76% on a year-on-year basis.
Rezolute, Inc. (NV) Share Price Chart
Rezolute, Inc. (NV) Quarterly Profit & Loss
All figures in USD
Rezolute, Inc. (NV) Annual Profit & Loss
All figures in USD
About Rezolute, Inc. (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Rezolute, Inc. (NV) Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.12 | $4.13 | -0.72% |
Sep 2026 | $4.67 | $4.16 | -16.31% |
Aug 2026 | $4.60 | $4.96 | +4.97% |
Jul 2026 | $5.28 | $4.73 | -8.95% |
Jun 2026 | $3.27 | $5.20 | +56.95% |
May 2026 | $3.17 | $3.31 | +3.44% |
Apr 2026 | $3.14 | $3.20 | +5.26% |
Mar 2026 | $3.04 | $3.04 | -5.30% |
Feb 2026 | $3.28 | $3.21 | -3.75% |
Jan 2026 | $2.34 | $3.33 | +41.01% |
Dec 2025 | $9.58 | $2.37 | -75.63% |
Nov 2025 | $9.19 | $9.71 | +3.96% |